Latest Insider Transactions at Guardant Health, Inc. (GH)
This section provides a real-time view of insider transactions for Guardant Health, Inc. (GH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Guardant Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Guardant Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 17
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-1.56%
|
$5,568
$48.2 P/Share
|
Jul 17
2025
|
Medina Manuel Hidalgo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,784
+50.0%
|
-
|
Jul 17
2025
|
Myrtle S Potter Director |
SELL
Open market or private sale
|
Direct |
26
-0.14%
|
$1,248
$48.2 P/Share
|
Jul 15
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.37%
|
-
|
Jul 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+3.25%
|
-
|
Jul 04
2025
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+0.59%
|
-
|
Jul 01
2025
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,365
-6.24%
|
$68,250
$50.71 P/Share
|
Jul 01
2025
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,691
+5.95%
|
-
|
Jul 01
2025
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,386
-3.0%
|
$69,300
$50.71 P/Share
|
Jul 01
2025
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,641
+2.81%
|
-
|
Jul 01
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,057
-2.4%
|
$52,850
$50.71 P/Share
|
Jul 01
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,084
+4.51%
|
-
|
Jul 01
2025
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,525
-1.84%
|
$76,250
$50.71 P/Share
|
Jul 01
2025
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,007
+1.8%
|
-
|
Jul 01
2025
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,714
-4.45%
|
$85,700
$50.71 P/Share
|
Jul 01
2025
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,381
+4.3%
|
-
|
Jul 01
2025
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,532
-3.04%
|
$76,600
$50.71 P/Share
|
Jul 01
2025
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,596
+3.51%
|
-
|
Jul 01
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,162
-0.5%
|
$608,100
$50.71 P/Share
|
Jul 01
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,997
+0.98%
|
-
|
Jul 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,162
-0.61%
|
$608,100
$50.71 P/Share
|
Jul 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,997
+1.19%
|
-
|
Jul 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-2.44%
|
$5,100,000
$51.04 P/Share
|
Jun 30
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,441
-0.1%
|
$126,932
$52.04 P/Share
|
Jun 30
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,815
+0.2%
|
-
|
Jun 30
2025
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+0.86%
|
-
|
Jun 30
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,441
-0.12%
|
$126,932
$52.04 P/Share
|
Jun 30
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,815
+0.23%
|
-
|
Jun 18
2025
|
Myrtle S Potter Director |
SELL
Open market or private sale
|
Direct |
26
-0.14%
|
$1,274
$49.47 P/Share
|
Jun 18
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
3,213
-30.89%
|
$157,437
$49.47 P/Share
|
Jun 17
2025
|
Ian T Clark Director |
SELL
Open market or private sale
|
Indirect |
6,672
-40.38%
|
$320,256
$48.38 P/Share
|
Jun 16
2025
|
Myrtle S Potter Director |
SELL
Open market or private sale
|
Direct |
2,626
-12.62%
|
$128,674
$49.7 P/Share
|
Jun 15
2025
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
535
-1.21%
|
$26,215
$49.29 P/Share
|
Jun 15
2025
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,020
+2.26%
|
-
|
Jun 15
2025
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
711
-1.98%
|
$34,839
$49.29 P/Share
|
Jun 15
2025
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,402
+3.77%
|
-
|
Jun 15
2025
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,675
-5.41%
|
$131,075
$49.29 P/Share
|
Jun 15
2025
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,281
+5.99%
|
-
|
Jun 15
2025
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
228
-1.18%
|
$11,172
$49.29 P/Share
|
Jun 15
2025
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
637
+3.18%
|
-
|
Jun 15
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,659
-3.8%
|
$81,291
$49.29 P/Share
|
Jun 15
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,272
+3.67%
|
-
|
Jun 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+2.35%
|
-
|
Jun 15
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69
+0.33%
|
-
|
Jun 13
2025
|
Meghan V. Joyce Director |
SELL
Open market or private sale
|
Direct |
3,337
-23.03%
|
$156,839
$47.22 P/Share
|
Jun 12
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,674
+39.66%
|
-
|
Jun 12
2025
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,674
+31.54%
|
-
|
Jun 12
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,674
+24.35%
|
-
|
Jun 12
2025
|
Ian T Clark Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
8,088
+32.86%
|
-
|
Jun 12
2025
|
Vijaya Gadde Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,674
+21.54%
|
-
|